IND 10-1 12 min The History of GBCA Use Val Runge, Bern / Switzerland IND 10-2 12 min AI and image reconstruction Lawrence Tanenbaum, New York / United States IND 10-3 12 min The Future of GBCA and other contrast media strategies Sarah Catoen,...
IND 14-1 10 min Detection and characterization of liver cancer: which agent and when? Alain Luciani, Creteil / France Importance of contrast enhanced MRI in detection for the liver cancer, similarities and differences between Hepatobiliary Contrast agents. IND...
IND 05-1 10 min From multidetector to dual energy CT: the impact on contrast injection protocols Mathias Prokop, Nijmegen / Netherlands To learn how the technology evolution in CT impacted the use of contrast media and injection protocol optimization. IND 05-2...
HYPMED 11-1 15 min Chairperson’s introduction: The HYPMED ambition Christiane K. Kuhl, Aachen / Germany At the end of the session, participants will be able to: 1. Understand the ambition and structure of HYPMED, a Horizon 2020 European collaborative...
Recent Comments